$OKLO

DeWitte Jacob sold $1.5M of OKLO

DeWitte Jacob (Co-Founder, CEO) sold 40,000 shares of Oklo Inc. (OKLO) at $38.40 ($1.54M total) on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeWitte Jacob
Published Sep 2, 2026, 8:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosed sale is the first public report of this transaction, providing new data for traders

02

Market read

Routine insider sale with modest size; limited immediate market impact

03

What to watch

Potential tax planning or liquidity needs for the insider

Relevance 5/10Novelty 4/10Timing: filing date 2026-09-02

Background

Form 4 filings disclose insider transactions; a 10b5-1 plan indicates pre-scheduled sales

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

CEO Jacob DeWitte sold 40,000 shares for $1.536M via a 10b5-1 plan

Expected impact

Potential short-term downward pressure

Evidence & confidence

Sale size is modest relative to holdings; no immediate catalyst beyond routine 10b5-1 execution

Market effects

Minimal impact on nuclear energy sector

None

Low

Counterpoint

Insider sale could be unrelated to company outlook; may present buying opportunity if price overreacts

Key entities

  • Oklo Inc.

    Nuclear technology firm listed on Nasdaq

  • Jacob DeWitte

    Co-Founder and CEO of Oklo

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNUCMed

A New Nuclear Rival Recently Filed to Go Public. Should Oklo Investors Be Worried?

Holtec Nuclear Corporation filed for an IPO on Nasdaq (ticker HNUC), generating $165M revenue and $17.8M net income in Q1 2024. Unlike Oklo (OKLO), Holtec has existing revenue and earnings, focusing on nuclear equipment, waste management, and SMR development. Holtec plans to use IPO proceeds for SMR programs and expansion. Oklo, a pre-commercial nuclear startup, has minimal revenue and significant losses, raising concerns for investors.

$CCJMedAI 8/10

AI Energy Demands Surge, Nuclear Power Seeks to Break the Deadlock

Nuclear energy sector is poised for long-term growth due to rising AI data center demand and government policies. Cameco (CCJ) benefits from uranium mining and reactor manufacturing. GE Vernova (GEV) is developing small modular reactors with a project scheduled for 2029. High-risk startups Oklo (OKLO) and NuScale Power (SMR) are seeking commercial agreements for future deployment.

MedAI 8/10

Oklo aims to turn nuclear waste into clean energy

Oklo Inc. plans to invest $1.68B to build a nuclear fuel recycling facility in Oak Ridge, converting used nuclear fuel into reusable materials. The company aims to address rising electricity demand and domestic HALEU supply shortages. Christina Leggett, director of fuel cycle technology, leads the project, leveraging pyroprocessing technology.

$OKLOMed

Oklo Climbs 12% As Supply Concerns Spark Rally In Advanced Nuclear Stocks

Oklo (OKLO) stock rose 12% to $44 on supply concerns amid U.S.-Canada trade tensions, adding $850M to its market cap. The company's Aurora reactors rely on advanced fuels, and recent political developments highlight risks tied to material access. Oklo has strong cash reserves ($3.01B) and operational milestones, like its Groves reactor reaching criticality. Analysts' price targets range from $14 to $130, with an average of $80.